432 related articles for article (PubMed ID: 29969654)
1. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
[TBL] [Abstract][Full Text] [Related]
2. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.
Emerson J; Delgado T; Girardi P; Johnson GVW
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047031
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
Quinn BR; Yunes-Medina L; Johnson GVW
J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
[TBL] [Abstract][Full Text] [Related]
6. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Colak G; Johnson GV
Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
[TBL] [Abstract][Full Text] [Related]
7. Deletion of transglutaminase 2 from astrocytes significantly improves their ability to promote neurite outgrowth on an inhibitory matrix.
Emerson J; Delgado T; Girardi P; Johnson GV
bioRxiv; 2023 Feb; ():. PubMed ID: 36798305
[TBL] [Abstract][Full Text] [Related]
8. Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury.
Elahi A; Emerson J; Rudlong J; Keillor JW; Salois G; Visca A; Girardi P; Johnson GVW; Pröschel C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831164
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.
Yunes-Medina L; Feola J; Johnson GVW
Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946
[TBL] [Abstract][Full Text] [Related]
10. Stabilizing transglutaminase 2 in the open conformation results in reactive astrocytes being more neurosupportive.
Emerson J; Delgado T; Hong M; Keillor JW; Johnson GV
bioRxiv; 2024 Apr; ():. PubMed ID: 38659783
[TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
[TBL] [Abstract][Full Text] [Related]
13. The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.
Rudlong J; Cheng A; Johnson GVW
Anal Biochem; 2020 Feb; 591():113556. PubMed ID: 31866289
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
[TBL] [Abstract][Full Text] [Related]
15. Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.
Yunes-Medina L; Paciorkowski A; Nuzbrokh Y; Johnson GVW
Mol Cell Neurosci; 2018 Jan; 86():72-80. PubMed ID: 29197584
[TBL] [Abstract][Full Text] [Related]
16. Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone.
Yin X; Feng L; Ma D; Yin P; Wang X; Hou S; Hao Y; Zhang J; Xin M; Feng J
J Neuroinflammation; 2018 Mar; 15(1):97. PubMed ID: 29587860
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination.
Espitia Pinzon N; Sanz-Morello B; Brevé JJ; Bol JG; Drukarch B; Bauer J; Baron W; van Dam AM
Sci Rep; 2017 Jan; 7():40995. PubMed ID: 28128219
[TBL] [Abstract][Full Text] [Related]
18. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
